Industry Focus
This Week's Top Healthcare News Could Cause These Stocks Pop or Drop
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:23
- Mas informaciones
Informações:
Sinopsis
Novartis nabs approval for a drug that could revolutionize how we treat heart disease and CVS Health doubles down on its anti-tobacco stance. Our Motley Fool's Michael Douglass and Todd Campbell discuss what it means for the companies involved.
